PUBLISHER: The Business Research Company | PRODUCT CODE: 1946639
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946639
Occlusion devices are medical tools designed to block or restrict the flow of blood or other fluids, commonly used in procedures like embolization to treat aneurysms, vascular abnormalities, or bleeding.
The main product categories of occlusion devices include occlusion removal devices, embolization devices, tubal occlusion devices, and support devices. Occlusion removal devices are medical instruments developed to eliminate blockages in blood vessels or other bodily passages. These devices are used in applications such as neurology, cardiology, peripheral vascular disease treatment, urology, oncology, and gynecology, and the end users include hospitals, diagnostic and surgical centers, ambulatory care centers, research laboratories, and academic institutions.
Tariffs have influenced the occlusion devices market by raising costs of imported medical-grade metals, polymers, and catheter components. Embolization and occlusion removal devices are most impacted, particularly in North America and Europe where reliance on global suppliers is high. Increased prices have affected procurement budgets for hospitals and surgical centers. On the positive side, tariffs are accelerating local manufacturing initiatives and partnerships, improving supply security and regional production capabilities.
The occlusion devices market research report is one of a series of new reports from The Business Research Company that provides occlusion devices market statistics, including occlusion devices industry global market size, regional shares, competitors with a occlusion devices market share, detailed occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the occlusion devices industry. This occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The occlusion devices market size has grown strongly in recent years. It will grow from $4.2 billion in 2025 to $4.6 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increase in cardiovascular diseases, advancements in interventional radiology, aging population growth, hospital infrastructure expansion, clinical adoption of embolization.
The occlusion devices market size is expected to see strong growth in the next few years. It will grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growth in neurological disorders, rising minimally invasive surgeries, technological device innovation, expanding ambulatory care centers, favorable reimbursement policies. Major trends in the forecast period include shift toward minimally invasive procedures, rising use of catheter-based therapies, increasing preference for embolization procedures, growth in neurovascular interventions, demand for high-precision occlusion devices.
The growing demand for minimally invasive techniques is increasingly supporting the expansion of the occlusion devices market going forward. Minimally invasive surgical techniques utilize small incisions or natural body openings to access internal organs and tissues while minimizing physical trauma. These approaches offer clinical, financial, and aesthetic benefits, including reduced recovery time and fewer complications, making them increasingly attractive to patients and healthcare providers. Occlusion devices are used in minimally invasive procedures to block or close blood vessels, ducts, or abnormal pathways and are commonly applied in interventional cardiology, radiology, and related specialties. For example, in June 2024, the International Society of Aesthetic Plastic Surgery reported that total aesthetic procedures approached 35 million in 2023, with combined surgical and non-surgical procedures increasing by 3.4% to reach 34.9 million. As a result, rising demand for minimally invasive techniques is reinforcing growth in the occlusion devices market.
Leading companies in the occlusion devices market are prioritizing the development of innovative solutions, including next-generation devices, to enhance targeted embolization procedures. A next-generation device represents an advanced iteration of existing technology that delivers improved performance, enhanced features, and innovative functionality. For example, in July 2025, Embolx, a US-based medical equipment manufacturer, introduced the Sniper G3 Balloon Occlusion Microcatheter to improve targeted embolization with greater efficiency, ease of use, and extended shelf life. This third-generation device doubles shelf life to 24 months, improving inventory flexibility. Developed using direct feedback from interventional radiologists, it offers enhanced trackability and a simplified preparation process that reduces setup time to under one minute, streamlining workflows and improving procedural outcomes.
In November 2023, Amring Pharmaceuticals Inc., a US-based specialty pharmaceutical company, acquired Laminar Inc. for an undisclosed amount. This acquisition combines Nordic Pharma's pharmaceutical expertise with Visant's FDA-cleared hyaluronic acid derivative, LACRIFILL, a canalicular occlusive device designed to temporarily block tear drainage by occluding the canalicular system. Visant Medical Inc. is a US-based medical device manufacturer focused on treatments for dry eye disease.
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The occlusion devices market consists of sales of liquid embolic agents, flow diverters, balloon occlusion devices, emblemization coils, and endovascular stents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Occlusion Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for occlusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The occlusion devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.